PDGFRB and neoplasm: The hyperactivation of this receptor facilitates neovascularization and enhances the survival of malignant cells, rendering PDGFRβ a highly promising therapeutic target for both inhibiting tumor growth and increasing sensitivity to systemic treatments [45,46].